SRX Global adds minority equity stake in Onconetix

ONCO•2026-09-24

SRX Global added a minority equity stake in Onconetix as it repositions its portfolio. The update also covered liquidations of holdings in Vistagen Therapeutics and Greenland Mines.

1. Portfolio changes

SRX Global added an equity investment in Onconetix and liquidated holdings in Vistagen Therapeutics and Greenland Mines. Onconetix has announced an agreement to acquire Realbotix, which develops robotic eyeball hardware integrated with an AI vision system.

SRX Global adds minority equity stake in Onconetix

1. Portfolio changes

Related News

Korn Ferry names Amber Foucault chief product and technology officer in talent unit

Nasdaq pauses STAK trading for volatility at 12:04 p.m.

Senate inches closer to US infrastructure permitting reform bill

Yields elevated as inflation fears keep markets on edge

MS NOW and CNN say they have been granted White House access